Evidence map›Paper›PMID 25849372›Full record

ArticlePloS one2015

Apolipoprotein-A1 as a damage-associated molecular patterns protein in osteoarthritis: ex vivo and in vitro pro-inflammatory properties.

Dominique de Seny, Gaël Cobraiville, Edith Charlier, Sophie Neuville, Laurence Lutteri, Caroline Le Goff, Denis Malaise, Olivier Malaise, Jean-Paul Chapelle, Biserka Relic and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Apolipoprotein A (ApoA) in Neurological Disorders: Connections and Insights.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Dominique de SenyLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Gaël CobraivilleLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Edith CharlierLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Sophie NeuvilleLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Laurence LutteriLaboratory of Clinical Chemistry, CHU Hospital of Liege, 4000 Liège, Belgium.
Caroline Le GoffLaboratory of Clinical Chemistry, CHU Hospital of Liege, 4000 Liège, Belgium.
Denis MalaiseLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Olivier MalaiseLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Jean-Paul ChapelleLaboratory of Clinical Chemistry, CHU Hospital of Liege, 4000 Liège, Belgium.
Biserka RelicLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
Michel G MalaiseLaboratory of Rheumatology, GIGA Research, University of Liege and CHU Hospital of Liege, 4000 Liège, Belgium.
University of Liège · BECentre Hospitalier Universitaire de Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is associated with a local inflammatory process. Dyslipidemia is known to be an underlying cause for the development of OA. Therefore, lipid and inflammatory levels were quantified ex vivo in blood and synovial fluid of OA patients (n=29) and compared to those of rheumatoid arthritis (RA) patients (n=27) or healthy volunteers (HV) (n=35). The role of apolipoprotein A-I (ApoA1) was investigated in vitro on inflammatory parameters using human joint cells isolated from cartilage and synovial membrane obtained from OA patients after joint replacement. Cells were stimulated with ApoA1 in the presence or not of serum amyloid A (SAA) protein and/or lipoproteins (LDL and HDL) at physiological concentration observed in OA synovial fluid. In our ex vivo study, ApoA1, LDL-C and total cholesterol levels were strongly correlated to each other inside the OA joint cavity whereas same levels were not or weakly correlated to their corresponding serum levels. In OA synovial fluid, ApoA1 was not as strongly correlated to HDL as observed in OA serum or in RA synovial fluid, suggesting a dissociative level between ApoA1 and HDL in OA synovial fluid. In vitro, ApoA1 induced IL-6, MMP-1 and MMP-3 expression by primary chondrocytes and fibroblast-like synoviocytes through TLR4 receptor. HDL and LDL attenuated joint inflammatory response induced by ApoA1 and SAA in a ratio dependent manner. In conclusion, a dysregulated lipidic profile in the synovial fluid of OA patients was observed and was correlated with inflammatory parameters in the OA joint cavity. Pro-inflammatory properties of ApoA1 were confirmed in vitro.

Indexed as

AdultAgedAged, 80 and overApolipoprotein A-ICells, CulturedChondrocytesFemaleHumansInterleukin-6LipopolysaccharidesMaleMatrix Metalloproteinase 1Matrix Metalloproteinase 3Middle AgedOsteoarthritisPrimary Cell CultureApolipoprotein A-IIL6 protein, humanInterleukin-6LipopolysaccharidesMatrix Metalloproteinase 1Matrix Metalloproteinase 3MMP1 protein, humanMMP3 protein, humanTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID25849372
PMCPMC4388661
OpenAlexW2044893051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.